Drug Profile
Falipamil
Alternative Names: AQA 39Latest Information Update: 23 Jun 1995
Price :
$50
*
At a glance
- Originator Boehringer Ingelheim Pharma KG
- Class Anti-ischaemics; Antiarrhythmics; Phthalimides; Small molecules
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ischaemic heart disorders; Sinus tachycardia
Most Recent Events
- 23 Jun 1995 Discontinued-II for Ischaemic heart disorders in Germany (IV)
- 23 Jun 1995 Discontinued-II for Ischaemic heart disorders in Germany (PO)
- 23 Jun 1995 Discontinued-II for Sinus tachycardia in Germany (IV)